Tumor microenvironment in giant cell tumor of bone: evaluation of PD-L1 expression and SIRPα infiltration after denosumab treatment

Giant cell tumor of bone (GCTB) is an intermediate malignant bone tumor that is locally aggressive and rarely metastasizes. Denosumab, which is a receptor activator of nuclear factor kappa B ligand (RANKL) inhibitor, can be used to treat GCTB. We focused on potential immunotherapy for GCTB and inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Toda, Yu, Kohashi, Kenichi, Yamamoto, Hidetaka, Ishihara, Shin, Ito, Yoshihiro, Susuki, Yosuke, Kawaguchi, Kengo, Kiyozawa, Daisuke, Takamatsu, Dai, Kinoshita, Izumi, Yamada, Yuichi, Maehara, Junki, Kimura, Atsushi, Tamiya, Sadafumi, Taguchi, Kenichi, Matsunobu, Tomoya, Matsumoto, Yoshihiro, Nakashima, Yasuharu, Mawatari, Masaaki, Oda, Yoshinao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292371/
https://www.ncbi.nlm.nih.gov/pubmed/34285260
http://dx.doi.org/10.1038/s41598-021-94022-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292371/
https://www.ncbi.nlm.nih.gov/pubmed/34285260
http://dx.doi.org/10.1038/s41598-021-94022-w

Ejemplares similares